Ancient herbal mix could boost liver health in advanced cancer

NCT ID NCT07691645

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This trial tests whether adding a Chinese herbal formula called Shuganhuazhuo to standard anti-cancer therapy can improve liver function and survival in people with advanced hepatocellular carcinoma (the most common type of liver cancer). The study includes 120 adults who are about to start second- or third-line treatment. Half receive the herbal decoction twice daily for six months alongside their regular care; the other half receive standard care alone. Researchers measure liver reserve function using a dye clearance test every two months and track overall survival and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Shuganhuazhuo Formula (Chinese herbal medicine)
What this could lead to
If it works, this could offer a way to protect liver function and extend survival for people with advanced liver cancer who have limited treatment options.
What could go wrong
This is a mid-stage trial with 120 participants, so results are not definitive. Herbal formulas can vary in quality and may interact with other drugs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHINESE HERBAL MEDICINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Zhejiang Cancer Hospital

    Hangzhou, Zhejiang, 310022, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.